vs
Side-by-side financial comparison of Solventum (SOLV) and SS&C Technologies Holdings Inc (SSNC). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.6B, roughly 1.2× SS&C Technologies Holdings Inc). SS&C Technologies Holdings Inc runs the higher net margin — 13.7% vs 3.2%, a 10.6% gap on every dollar of revenue. On growth, SS&C Technologies Holdings Inc posted the faster year-over-year revenue change (8.8% vs -3.7%). Over the past eight quarters, SS&C Technologies Holdings Inc's revenue compounded faster (6.5% CAGR vs -0.4%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
SS&C Technologies Holdings, Inc. is an American multinational holding company headquartered in Windsor, Connecticut, that sells software and software as a service to the financial services industry. The company has offices in the Americas, Europe, Asia, Africa and Australia.
SOLV vs SSNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.6B |
| Net Profit | $63.0M | $226.1M |
| Gross Margin | 51.4% | 48.7% |
| Operating Margin | 6.3% | 24.2% |
| Net Margin | 3.2% | 13.7% |
| Revenue YoY | -3.7% | 8.8% |
| Net Profit YoY | 103.2% | 6.2% |
| EPS (diluted) | $0.37 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.6B | ||
| Q4 25 | $2.0B | $1.7B | ||
| Q3 25 | $2.1B | $1.6B | ||
| Q2 25 | $2.2B | $1.5B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $2.1B | $1.5B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $2.1B | $1.5B |
| Q1 26 | — | $226.1M | ||
| Q4 25 | $63.0M | $193.1M | ||
| Q3 25 | $1.3B | $210.0M | ||
| Q2 25 | $90.0M | $180.8M | ||
| Q1 25 | $137.0M | $213.0M | ||
| Q4 24 | $31.0M | $248.2M | ||
| Q3 24 | $122.0M | $164.4M | ||
| Q2 24 | $89.0M | $190.3M |
| Q1 26 | — | 48.7% | ||
| Q4 25 | 51.4% | 47.8% | ||
| Q3 25 | 54.2% | 47.7% | ||
| Q2 25 | 54.4% | 48.0% | ||
| Q1 25 | 53.8% | 49.3% | ||
| Q4 24 | 53.9% | 49.3% | ||
| Q3 24 | 56.0% | 48.0% | ||
| Q2 24 | 54.6% | 48.1% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 6.3% | 22.3% | ||
| Q3 25 | 80.6% | 23.3% | ||
| Q2 25 | 9.9% | 22.4% | ||
| Q1 25 | 7.3% | 23.6% | ||
| Q4 24 | 6.6% | 23.4% | ||
| Q3 24 | 13.2% | 22.2% | ||
| Q2 24 | 11.7% | 22.6% |
| Q1 26 | — | 13.7% | ||
| Q4 25 | 3.2% | 11.7% | ||
| Q3 25 | 60.4% | 13.4% | ||
| Q2 25 | 4.2% | 11.8% | ||
| Q1 25 | 6.6% | 14.1% | ||
| Q4 24 | 1.5% | 16.2% | ||
| Q3 24 | 5.9% | 11.2% | ||
| Q2 24 | 4.3% | 13.1% |
| Q1 26 | — | $0.91 | ||
| Q4 25 | $0.37 | $0.76 | ||
| Q3 25 | $7.22 | $0.83 | ||
| Q2 25 | $0.51 | $0.72 | ||
| Q1 25 | $0.78 | $0.84 | ||
| Q4 24 | $0.18 | $0.98 | ||
| Q3 24 | $0.70 | $0.65 | ||
| Q2 24 | $0.51 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $878.0M | $420.9M |
| Total DebtLower is stronger | $5.0B | $7.4B |
| Stockholders' EquityBook value | $5.0B | $6.9B |
| Total Assets | $14.3B | $20.3B |
| Debt / EquityLower = less leverage | 1.00× | 1.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $420.9M | ||
| Q4 25 | $878.0M | $462.1M | ||
| Q3 25 | $1.6B | $388.3M | ||
| Q2 25 | $492.0M | $480.3M | ||
| Q1 25 | $534.0M | $515.0M | ||
| Q4 24 | $762.0M | $567.1M | ||
| Q3 24 | $772.0M | $694.7M | ||
| Q2 24 | $897.0M | $462.7M |
| Q1 26 | — | $7.4B | ||
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $7.8B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.0B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.3B | — |
| Q1 26 | — | $6.9B | ||
| Q4 25 | $5.0B | $6.9B | ||
| Q3 25 | $5.0B | $6.9B | ||
| Q2 25 | $3.6B | $6.9B | ||
| Q1 25 | $3.3B | $6.8B | ||
| Q4 24 | $3.0B | $6.5B | ||
| Q3 24 | $3.2B | $6.8B | ||
| Q2 24 | $2.9B | $6.4B |
| Q1 26 | — | $20.3B | ||
| Q4 25 | $14.3B | $20.7B | ||
| Q3 25 | $14.0B | $19.5B | ||
| Q2 25 | $15.1B | $19.0B | ||
| Q1 25 | $14.5B | $20.4B | ||
| Q4 24 | $14.5B | $19.0B | ||
| Q3 24 | $14.7B | $18.4B | ||
| Q2 24 | $14.6B | $16.9B |
| Q1 26 | — | 1.08× | ||
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.14× | — | ||
| Q1 25 | 2.43× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 2.90× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.0M | $299.7M |
| Free Cash FlowOCF − Capex | $32.0M | — |
| FCF MarginFCF / Revenue | 1.6% | — |
| Capex IntensityCapex / Revenue | 3.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.51× | 1.33× |
| TTM Free Cash FlowTrailing 4 quarters | $-10.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $299.7M | ||
| Q4 25 | $95.0M | $643.5M | ||
| Q3 25 | $76.0M | $456.2M | ||
| Q2 25 | $169.0M | $372.9M | ||
| Q1 25 | $29.0M | $272.2M | ||
| Q4 24 | $219.0M | $486.6M | ||
| Q3 24 | $169.0M | $336.6M | ||
| Q2 24 | $355.0M | $384.9M |
| Q1 26 | — | — | ||
| Q4 25 | $32.0M | $633.0M | ||
| Q3 25 | $-21.0M | $421.5M | ||
| Q2 25 | $59.0M | $350.0M | ||
| Q1 25 | $-80.0M | $259.5M | ||
| Q4 24 | $92.0M | $466.9M | ||
| Q3 24 | $76.0M | $310.7M | ||
| Q2 24 | $297.0M | $374.9M |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 38.3% | ||
| Q3 25 | -1.0% | 26.9% | ||
| Q2 25 | 2.7% | 22.8% | ||
| Q1 25 | -3.9% | 17.1% | ||
| Q4 24 | 4.4% | 30.5% | ||
| Q3 24 | 3.7% | 21.2% | ||
| Q2 24 | 14.3% | 25.8% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 3.2% | 0.6% | ||
| Q3 25 | 4.6% | 2.2% | ||
| Q2 25 | 5.1% | 1.5% | ||
| Q1 25 | 5.3% | 0.8% | ||
| Q4 24 | 6.1% | 1.3% | ||
| Q3 24 | 4.5% | 1.8% | ||
| Q2 24 | 2.8% | 0.7% |
| Q1 26 | — | 1.33× | ||
| Q4 25 | 1.51× | 3.33× | ||
| Q3 25 | 0.06× | 2.17× | ||
| Q2 25 | 1.88× | 2.06× | ||
| Q1 25 | 0.21× | 1.28× | ||
| Q4 24 | 7.06× | 1.96× | ||
| Q3 24 | 1.39× | 2.05× | ||
| Q2 24 | 3.99× | 2.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
SSNC
| Technology-enabled services | $1.4B | 85% |
| License, maintenance and related | $239.8M | 15% |
